Item 8.01 Other Events.



On November 3, 2021, NeoPhotonics Corporation, a Delaware corporation
("NeoPhotonics" or the "Company"), Lumentum Holdings Inc., a Delaware
corporation ("Lumentum" or "Parent"), and Neptune Merger Sub, Inc., a Delaware
corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), entered
into an Agreement and Plan of Merger (the "Merger Agreement").

Pursuant to the terms of the Merger Agreement, NeoPhotonics will be acquired by
Lumentum through a merger of Merger Sub with and into NeoPhotonics (the
"Merger"), with NeoPhotonics surviving the Merger as a wholly owned subsidiary
of Lumentum.

In connection with the proposed merger, NeoPhotonics filed a preliminary proxy
statement with the Securities and Exchange Commission (the "SEC") on December 1,
2021 (the "Preliminary Proxy Statement"), and NeoPhotonics filed a definitive
proxy statement with the SEC on December 23, 2021 (the "Definitive Proxy
Statement"). The Company commenced mailing the Definitive Proxy Statement on or
about December 23, 2021.

Between December 3, 2021 and January 5, 2022, ten lawsuits (captioned Elaine
Wang v. NeoPhotonics Corporation, et al., No. 1:21-cv-10338 (S.D.N.Y. filed Dec.
3, 2021), Mengsheng Ku v. NeoPhotonics Corporation, et al., No. 5:21-cv-09479
(N.D. Cal. filed Dec. 8, 2021), Heather Smith v. NeoPhotonics Corporation, et
al., No. 1:21-cv-10698 (S.D.N.Y. filed Dec. 14, 2021), Matthew Hopkins v.
NeoPhotonics Corporation, et al., No. 1:21-cv-10725 (S.D.N.Y. filed Dec. 15,
2021), James Hendrickson v. NeoPhotonics Corporation, et al., No. 1:21-cv-06919
(E.D.N.Y. filed Dec. 15, 2021), Stephen Bushansky v. NeoPhotonics Corporation et
al., Case No. 5:21-cv-09825 (N.D. Cal. filed Dec. 20, 2021), Alex Ciccotelli v.
NeoPhotonics Corporation et al., Case No. 2:21-cv-05611 (E.D. Pa. filed Dec. 23,
2021), Christopher Taylor v. NeoPhotonics Corporation et al., Case No.
1:22-cv-00002 (D. Del. filed Jan. 3, 2022), John Ryan v. NeoPhotonics
Corporation et al., Case No. 1:22-cv-00046 (S.D.N.Y. filed Jan. 4, 2022), and
James Parshall v. NeoPhotonics Corporation et al., Case No. 5:22-cv-00055 (N.D.
Cal. filed Jan. 5, 2022)), were filed in federal court by alleged NeoPhotonics
stockholders challenging the Merger. The complaints name NeoPhotonics and
NeoPhotonics' board of directors as defendants. The complaints assert violations
of Section 14(a) of the Exchange Act, Rule 14a-9 promulgated thereunder, and 17
C.F.R. § 244.100 against NeoPhotonics and the individual defendants, as well as
violations of Section 20(a) of the Exchange Act against the individual
defendants. The plaintiffs contend that the Preliminary Proxy Statement filed
with the SEC on December 1, 2021, or the Definitive Proxy Statement filed with
the SEC on December 23, 2021, omitted or misrepresented material information
regarding the Merger. The complaints seek injunctive relief, rescission, or
rescissory damages, dissemination of a proxy statement that discloses certain
information requested by the plaintiffs, and an award of plaintiffs' costs,
including attorneys' fees and expenses.

Between December 20 and December 22, 2021, the Company also received two demand
letters from purported stockholders of the Company challenging the Merger and
asserting that the Preliminary Proxy Statement omitted or misrepresented
material information regarding the Merger.

NeoPhotonics believes that no further disclosure is required to supplement the
Definitive Proxy Statement under applicable laws. However, to minimize the
expense and distraction of responding to such actions and letters, NeoPhotonics
is providing additional disclosures related to the Merger and transactions
related thereto, which are set forth below, supplementing the disclosures in the
Definitive Proxy Statement (the "Supplemental Disclosures"). Nothing in this
Current Report on Form 8-K shall be deemed an admission of the legal necessity
or materiality under applicable laws of any of the Supplemental Disclosures set
forth herein. To the contrary, the Company specifically denies all allegations
in the complaints that any additional disclosure was or is required.

These Supplemental Disclosures will not affect the merger consideration to be
paid to the Company's stockholders in connection with the Merger or the timing
of the Company's virtual special meeting of stockholders scheduled to be held
online via live webcast on February 1, 2022 at 9:00 a.m., Pacific Time, at
https://web.lumiagm.com/290418259. The Board of Directors unanimously
recommends, on behalf of NeoPhotonics that you vote: (1) "FOR" the adoption of
the Merger Agreement; (2) "FOR" the approval, on an advisory (non-binding)
basis, of the Compensation Proposal; and (3) "FOR" the Adjournment Proposal.

Supplemental Disclosures to the Definitive Proxy Statement/Prospectus



The following Supplemental Disclosures should be read in conjunction with the
Definitive Proxy Statement, which should be read in its entirety. To the extent
that information in the Supplemental Disclosures differs from or updates
information contained in the Definitive Proxy Statement, the information in the
supplemental disclosures shall supersede or supplement the information in the
Proxy Statement. Defined terms used but not defined in the Supplemental
Disclosures have the meanings set forth in the Definitive Proxy Statement.
Paragraph and page references used herein refer to the Definitive Proxy
Statement before any additions or deletions resulting from the Supplemental
Disclosures.

--------------------------------------------------------------------------------

The following underlined language is added to the first paragraph that appears on page 28 in the section of the Definitive Proxy Statement entitled "The Merger-Background of the Merger."



In connection with such reviews, on January 13, 2016, the Board had formed a
strategic committee (the "Strategic Committee") to assist with efficient and
responsive oversight and management of such strategic matters. The Strategic
Committee for the period of time referenced below consisted of Charles J. Abbe,
Rajiv Ramaswami and Michael J. Sophie, and the Board determined it advisable to
engage them to help oversee and manage the discussions with Lumentum and other
potential strategic acquirors. Messrs. Abbe, Ramaswami, and Sophie were chosen
because they are independent directors, have substantial experience in mergers &
acquisitions, strategic planning, and corporate governance, and have years of
related experience in the industry.

The following underlined language is added to the second full paragraph that
appears on page 29 in the section of the Definitive Proxy Statement entitled
"The Merger-Background of the Merger."

During the months of September and October 2020, Mr. Jenks and representatives
of Union Square contacted and had conversations with certain additional
potential counterparties as authorized by the Strategic Committee, including as
detailed below. In connection with such solicitations, the Company entered into
non-disclosure agreements with certain parties, including Parent, to provide
additional due diligence information. Each of the non-disclosure agreements
entered into with the counterparties had a standstill agreement, which did not
contain a "don't ask, don't waive" clause. Except for the standstill agreement
with Party A, each of the standstill agreements contained (i) a carveout that
allowed the counterparty to make a confidential acquisition proposal to acquire
the Company and (ii) a clause terminating the standstill in the event an
unaffiliated third party commenced a tender offer or made a public proposal for
a merger or other business combination.

The following underlined language is added to the last paragraph that appears on page 36 and continues onto page 37 in the section of the Definitive Proxy Statement entitled "The Merger-Background of the Merger."



On December 14, 2020, Party E and the Company executed a non-disclosure
agreement, which included a standstill provision that would not prevent Party E
from making a confidential acquisition proposal. Following execution of the
non-disclosure agreement with Party E, representatives of the Company and Union
Square conducted a number of due diligence meetings with Party E and its
financial advisor between December 14, 2020 and December 31, 2020.

The following underlined language is added to the last paragraph that appears on page 52 in the section of the Definitive Proxy Statement entitled "The Merger-Recommendation of the Board of Directors and Reasons for the Merger-Financial Projections."


                   Long Range Plan and Related Extrapolations



CYE December 31 | $ in millions                Q42021E         CY2022E(12)  

CY203E(12) CY2024E CY2025E CY2026E Revenue

$     100       $         416 

$ 483 $ 551 $ 622 $ 703 Non-GAAP Gross Profit(1)

$      28       $         122 

$ 153 $ 190 $ 232 $ 281 Non-GAAP Operating Profit before SBC(2) $ 5 $ 18

$        33       $      58       $      89       $     120
Adjusted EBITDA(3)                            $      10       $          47       $        66       $      95       $     128       $     162
Depreciation & Amortization                   ($      6 )     ($         29 )     ($       34 )     ($     37 )     ($     39 )     ($     42 )

Stock-Based Compensation                      ($      3 )     ($         18 )     ($       21 )     ($     22 )     ($     23 )     ($     24 )

Non-GAAP Operating Profit after SBC(4)        $       2       $           0 

$ 12 $ 36 $ 66 $ 96 Non-GAAP Net Income(5)

$       1       ($          1 

) $ 8 $ 27 $ 51 $ 75 Non-GAAP Unlevered Net Income(6)

$       1       ($          0 )     $         9       $      28       $      52       $      76
Depreciation and Amortization                 $       6       $          29       $        34       $      37       $      39       $      42

Other Adjustments                             $       2       $           4       $         3       $       3       $       3       $       3

Change in Working Capital(7)                  ($     14 )     ($          6 )     ($       19 )     ($     21 )     ($     24 )     ($     27 )

Change in Deferred Taxes(8)                   ($      0 )     ($          1 )     ($        1 )     ($      1 )     ($      1 )     ($      1 )

Capital Expenditures                          ($      4 )     ($         25 )     ($       24 )     ($     28 )     ($     31 )     ($     35 )

Unlevered Free Cash Flow(9)                   ($     10 )     $           1

$ 2 $ 18 $ 38 $ 57 Pre-tax Profit for Cash Tax Provision(10)

            -        $           4       $        16       $      40       $      69       $     100
Tax Benefit of NOL(11)                               -        $           1       $         3       $       8       $      15       $      21

(1) Non-GAAP Gross Profit, a non-GAAP financial measure, is calculated as Revenue


    less total non-GAAP cost of goods sold (adjusted for stock-based
    compensation, amortization of intangibles, depreciation of
    acquisition-related fixed asset step-ups, EOL inventory write-downs,
    accelerated depreciation, and restructuring charges).

(2) Non-GAAP Operating Profit before SBC, a non-GAAP financial measure, is

calculated by starting with Non-GAAP Gross Profit and subtracting total

Non-GAAP Operating Expenses and excludes amortized integration, accelerated

depreciation, restructuring and other non-recurring charges.

(3) Adjusted EBITDA, a non-GAAP financial measure, is calculated by starting with

Non-GAAP Operating Profit before SBC and adding back depreciation and

amortization.

--------------------------------------------------------------------------------

(4) Non-GAAP Operating Profit after SBC, a non-GAAP financial measure, starts

with Non-GAAP Operating Profit before SBC and includes the impact of

stock-based compensation.

(5) Non-GAAP Net Income, a non-GAAP financial measure, is calculated by starting

with Non-GAAP Operating Profit after SBC and subtracting interest and other

expenses and tax expenses.

(6) Non-GAAP Unlevered Net Income, a non-GAAP financial measure, is calculated by

starting with Non-GAAP Net Income, adding back interest expense and

subtracting the impact of the tax shield on interest expense.

(7) Working Capital excludes Cash, Current Debt, Dividends Payable, and

Settlement.

(8) Estimated difference between cash tax and book tax, taking into account

estimated portion of tax deductible SBC expenses.

(9) Unlevered free cash flow, a non-GAAP financial measure, is calculated as

Non-GAAP Unlevered Net Income less capital expenditures and adding or

subtracting (as applicable) the net impact of depreciation, amortization and

other adjustments and changes in working capital and deferred taxes.

Stock-based compensation is treated as a cash expense to account for future

dilution impact and therefore is not added back.

(10) Pre-tax Profit for Cash Tax Provision is a non-GAAP financial measure that

adds back the impact of 33% of SBC in Q4 CY2021, trending down to 21% in

CY2026 based on Company management's view on the non-tax deductible portion

of current compensation plans for the purposes of calculating estimated

annual NOL usage.

(11) Tax benefits of NOLs calculated based on a statutory tax rate of 21% as

provided by management of the Company. Based on such rate and the amount of

NOLs of the Company as provided by the management of the Company, the tax

benefits of the NOLs were calculated for each calendar year through 2027

(the last year in which such NOLs would be utilized based on the pre-tax

profits), with a $1 million tax benefit arising in CY2027 (such amount not

reflected in the table above). With the approval of Company's management,

for purposes of a standalone company analysis, the calculations assumed that

the full amount of the Company's NOLs would be available to be utilized by

the Company and not subject to any limitations set forth under any

applicable tax law including Section 382 of the Internal Revenue Code.

(12) Management forecast for 2022E and 2023E revenue includes $60 million of

revenue from product design engagement not yet won.




The following underlined language is added to the second full paragraph that
appears on page 55 in the section of the Definitive Proxy Statement entitled
"The Merger-Opinion of Union Square Advisors LLC-Summary of Financial Analysis."

In performing the financial analysis summarized below and arriving at its
opinion, Union Square used and relied upon certain financial projections
provided by the management of NeoPhotonics and referred to in this proxy
statement as the "Management Forecast." Except as otherwise noted, Union Square
utilized in each of its analyses described below the number of outstanding
shares of NeoPhotonics common stock on a fully diluted basis, based on the
following inputs as prepared by the management of NeoPhotonics as of November 1,
2021 (applying the treasury stock method at the Unaffected Share Price of $11.52
per share), and provided by the management of NeoPhotonics to Union Square for
Union Square's use, which included (A) 52.7 million shares of common stock
outstanding, (B) 0.7 million Company Options outstanding exercisable at a
weighted-average exercise price of $5.10 per share, (C) 83,464 Company SAUs
outstanding and (D) 3.6 million Company RSUs outstanding. Union Square also used
and relied upon certain Wall Street financial projections based on FactSet
consensus estimates and referred to in this proxy statement as the "Consensus
Estimates."

The following underlined language is added to the fourth full paragraph that
appears on page 55 in the section of the Definitive Proxy Statement entitled
"The Merger-Opinion of Union Square Advisors LLC-Selected Publicly Traded
Company Analysis."

For purposes of this analysis, Union Square analyzed the following statistics as of November 3, 2021, for each of the selected comparable companies:





    •     The enterprise value (which is the market value as of November 3, 2021,

plus short and long-term debt less cash and short-term investments)

divided by estimated revenue for calendar year 2021, which is referred to


          below as Enterprise Value/CY2021E Revenue; and




    •     The enterprise value divided by estimated revenue for calendar year 2022,
          which is referred to below as Enterprise Value/CY2022E Revenue.




    •     The enterprise value divided by estimated revenue for calendar year 2023,

          which is referred to below as Enterprise Value/CY2023E Revenue.



• The enterprise value divided by Adjusted EBITDA ("Adjusted EBITDA" which

is estimated future earnings before interest, depreciation and

amortization and stock-based compensation and non-recurring items) for


          calendar year 2022, which is referred to below as Enterprise
          Value/CY2022E Adjusted EBITDA.



• The enterprise value divided by Adjusted EBITDA revenue for calendar year

2023, which is referred to below as Enterprise Value/CY2023E Adjusted

EBITDA.

--------------------------------------------------------------------------------


 Such multiples for each of the selected comparable companies are summarized in
                                the table below:



                                                                                    EV/CY2022E        EV/CY2023E
                                   EV/CY2021E      EV/CY2022E      EV/CY2023E       Adjusted          Adjusted
Selected Public Traded Companies   Revenue         Revenue         Revenue          EBITDA            EBITDA
II-VI Incorporated                        2.2x            2.0x            1.8x              7.9x              7.2x
Applied Optoelectronics, Inc.             1.6x            1.4x            1.3x              N.M.              N.M.
Ciena Corporation                         2.4x            2.2x            2.1x             11.8x             11.1x
EMCORE Corporation                        1.6x            1.4x             N/A *             N/A *             N/A *
Infinera Corporation                      1.7x            1.5x            1.4x             11.7x              9.3x
IPG Photonics Corporation                 5.5x            5.0x            4.6x             15.1x             13.4x
Lumentum Holdings Inc.                    3.6x            3.4x            3.2x              9.5x              8.9x




* Not available.

The following underlined language is added to the first full paragraph that appears on page 58 in the section of the Definitive Proxy Statement entitled "The Merger-Opinion of Union Square Advisors LLC-Precedent Transactions Analysis."

Union Square performed a precedent transactions analysis, which is designed to
imply a value of a company based on publicly available financial terms of
selected transactions. In connection with its analysis, Union Square compared
publicly available statistics for 27 selected transactions (which we refer to as
the selected precedent transactions) announced since December 2007, involving
optical communication components, including tunable lasers, chip-based
components, modules, wavelength management and switching. Utilizing its
professional judgment and expertise, Union Square selected the precedent
transactions because, based on Union Square's professional judgement and
expertise, they shared certain characteristics with the Merger. The following is
a list of the selected precedent transactions reviewed, the month and year each
transaction was announced, the multiples observed for each such transaction and
the enterprise values for each such transaction:



                                                                EV/LTM       EV/NTM             EV
Date Announced          Acquiror               Target          Revenue     

Revenue (in Millions)


  August 2021         Adtran, Inc.          Adva Optical           1.3x         1.2x                 $930
                                             Networking
 February 2021     II-VI Incorporated      Coherent, Inc.          5.5x         4.7x               $6,795
January 2021(1)   Cisco Systems, Inc.          Acacia             12.6x         9.4x               $4,696
                                           Communications,
                                                Inc.
 October 2020     Marvell Technology,     Inphi Corporation       17.8x        13.7x              $10,671
                          Inc.
 October 2019         Huber+Suhner              Bktel              1.2x         N.A. *                $53
  August 2019     Diodes Incorporated          Lite-On             1.5x         0.9x                 $337
                                            Semiconductor
                                             Corporation
 November 2018     II-VI Incorporated    Finisar Corporation       2.2x         2.0x               $2,887
  March 2018       Lumentum Holdings        Oclaro, Inc.           2.4x         2.6x               $1,485
                          Inc.
   July 2017          ADVA Optical       MRV Communications,       0.5x         0.4x                  $39
                     Networking SE              Inc.
 November 2016     Inphi Corporation          ClariPhy             7.6x         5.8x                 $275
                                           Communications,
                                                Inc.
   May 2016          IPG Photonics        Menara Networks,         2.2x         N.A. *                $47
                      Corporation               Inc.
  April 2016      Corning Incorporated     Alliance Fiber          3.6x         3.1x                 $260
                                           Optic Products,
                                                Inc.
  March 2016         Coherent, Inc.          Rofin-Sinar           1.5x         1.5x                 $789
                                         Technologies, Inc.
   May 2015        Ciena Corporation         Cyan, Inc.            2.5x         2.0x                 $296
 November 2014     Molex Incorporated          Oplink              1.5x         1.3x                 $313
                                           Communications,
                                                Inc.
 October 2013      II-VI Incorporated     Oclaro, Inc. (2)         0.9x         N.A. *                $89
September 2013     II-VI Incorporated     Oclaro, Inc. (3)         1.3x         1.6x                 $114
  April 2013       Avago Technologies      CyOptics, Inc.          1.9x         N.A. *               $400
                        Limited
 January 2013         NeoPhotonics       Lapis Semiconductor       0.6x         0.8x                  $35
                      Corporation           Co, Ltd. (4)
 December 2012           Exotic           Lightworks Optics        1.6x         N.A. *                $35
                     Electro-Optics
  March 2012          Oclaro, Inc.          Opnext, Inc.           0.4x         0.4x                 $132
   May 2011         IDEX Corporation      CVI Melles Griot         2.2x         N.A. *               $400
  March 2011      Finisar Corporation         Ignis ASA            3.0x         1.5x                 $118
   July 2010          Oclaro, Inc.       Mintera Corporation       1.5x         N.A. *                $30
--------------------------------------------------------------------------------

  July 2008         Opnext, Inc.             StrataLight          2.3x         N.A. *          $172
                                        Communications, Inc.
  May 2008       Finisar Corporation     Optium Corporation       1.2x         0.8x            $168
December 2007    Emcore Corporation     Intel Corporation (5)     1.4x         1.3x             $85




* Not available.


(1) Merger agreement amended from $70.00 per share in merger consideration

(announced July 2019) to $115.00 per share in merger consideration (announced

January 2021)

(2) Oclaro's Fiber Amplifier and Micro-Optics Business

(3) Oclaro's Switzerland-based Semiconductor Laser Business

(4) LAPIS Semiconductor's Semiconductor Optical Business Unit

(5) Telecom Assets of Intel's Optical Platform Division

The following underlined language is added to the last paragraph that appears on page 59 in the section of the Definitive Proxy Statement entitled "The Merger-Opinion of Union Square Advisors LLC-Discounted Cash Flow Analysis."

Union Square calculated a range of prices per share for NeoPhotonics based on a
discounted cash flow analysis to value NeoPhotonics as a standalone entity.
Union Square utilized for its analysis and with NeoPhotonics' consent, the
Management Forecast which consisted of the Financial Projections. Unlevered free
cash flow was derived as Non-GAAP Unlevered Net Income after stock-based
compensation, excluding non-recurring items adding back depreciation,
amortization and other items and subtracting for change in working capital,
deferred taxes and capital expenditures. Stock-based compensation was subtracted
in order to derive unlevered free cash flow and not added back in order to
capture the dilutive impact of future share issuances. Union Square calculated
the present value of unlevered free cash flows for the fourth quarter of
calendar year 2021 and 2022 through 2026 and terminal values in the calendar
year 2026, using discount rates, selected upon the application of Union Square's
professional judgment and experience and taking into account macro-economic
assumptions, estimates of risk and other appropriate factors, ranging from 9.3%
to 11.3%, which were based on a weighted average cost of capital calculation.
The terminal value was derived by applying perpetuity growth rates, selected
upon the application of Union Square's professional judgment and experience and
taking into account market expectations regarding long-term real growth rate of
gross domestic product, inflation and other appropriate factors, ranging from
3.5% to 4.5% and applied to the terminal year (2026) estimate of the unlevered
free cash flow. The resulting enterprise value ranges based on the present
values of the unlevered free cash flows, and terminal value was adjusted to add
net cash to derive a range of implied equity values. For the purposes of
calculating NeoPhotonics' use of its federal net operating loss carryforwards, a
nominal U.S. corporate tax rate of 21% was assumed, at the consent of management
of NeoPhotonics, for calendar years 2021 through 2026 and included adjustment
for any expiration of these net operating losses.

The following underlined language is added to the first paragraph that appears
on page 61 in the section of the Definitive Proxy Statement entitled "The
Merger-Opinion of Union Square Advisors LLC-Other Information-Research Analyst
Price Targets for NeoPhotonics Corporation."

Union Square reviewed publicly available research on per share price targets for
our common stock obtained from 11 equity research brokers, which are publicly
available. The equity research analysts' per share price targets ranged from
$10.00 to $16.00 per share for NeoPhotonics. In addition, the mean undiscounted
analyst per share price target for our common stock was $14.10. The publicly
available per share price targets published by equity research firms do not
necessarily reflect the current market trading price of our common stock, and
these estimates are subject to uncertainties, including future financial
performance of NeoPhotonics as well as future market conditions.

The following underlined language is added to the first full paragraph that appears on page 62 in the section of the Definitive Proxy Statement entitled "The Merger-Opinion of Union Square Advisors LLC-Other Information-General."



During the two-year period prior to the date of its opinion, Union Square has
not been engaged to provide financial advisory or other services to Parent (or
any of its affiliates) and has not received any compensation from Parent (or any
of its affiliates). During the two-year period prior to the date of its opinion,
Union Square had been engaged to provide financial advisory or other services to
NeoPhotonics (or any of its affiliates) but has not received any compensation
from NeoPhotonics (or any of its affiliates), other than in connection with the
Merger and the transactions related therewith. Union Square may provide
financial advisory or other services to NeoPhotonics, Parent or any of their
affiliates in the future, and in connection with any such services Union Square
may receive compensation.

--------------------------------------------------------------------------------

The following underlined language is added to the fifth full paragraph that . . .

© Edgar Online, source Glimpses